Issar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 55.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 55.00 Cr
as on 11-12-2024
- Company Age 29 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 28.25 Cr
as on 11-12-2024
- Revenue -98.03%
(FY 2022)
- Profit -105.85%
(FY 2022)
- Ebitda -136.00%
(FY 2022)
- Net Worth -0.71%
(FY 2022)
- Total Assets -4.83%
(FY 2022)
About Issar Pharmaceuticals
- CIN/LLPIN
U24239TG1995PTC022131
- Company No.
022131
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 1995
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Issar Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Isanaka  | Director | 02-Sep-1999 | Current |
| Isanaka Shaalini | Director | 12-Apr-2016 | Current |
Financial Performance and Corporate Structure Insights of Issar Pharmaceuticals.
Issar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.03% decrease. The company also saw a substantial fall in profitability, with a 105.85% decrease in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Issar Pharmaceuticals?
In 2022, Issar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Jun 2011 | ₹24.20 Cr | Satisfied |
Uti Bank Limited Creation Date: 05 Jun 2006 | ₹1.00 Cr | Satisfied |
The Karnataka Bank Limited Creation Date: 12 Nov 2005 | - | Satisfied |
How Many Employees Work at Issar Pharmaceuticals?
Unlock and access historical data on people associated with Issar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Issar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Issar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
